Results 311 to 320 of about 269,977 (355)

Recent progress in mRNA cancer vaccines. [PDF]

open access: yesHum Vaccin Immunother
Yao R, Xie C, Xia X.
europepmc   +1 more source

Hybrid Molecules as Efficient Drugs against Multidrug‐Resistant Malaria Parasites

open access: yesChemMedChem, EarlyView.
Among hybrid molecules currently developed as antimalarial drug candidates, emoquine‐1 exhibits high activity against all the multidrug‐resistant Plasmodium strains tested up to now, including artemisinin‐resistant quiescent parasites, critical parameters for promising antimalarial drugs. It is also curative in mouse malaria.
Anne Robert   +6 more
wiley   +1 more source

Intracellular and Extracellular Efficacy of Homoisoflavone Derivatives Against Mycobacterium tuberculosis: Progress Toward Novel Antitubercular Agents

open access: yesChemMedChem, Accepted Article.
Tuberculosis (TB) is the leading cause of death among infectious diseases, and new studies focusing new anti‐TB drugs are urgent due to the emergence of drug‐resistant strains. In this regard, homoisoflavones, an underexplored subgroup of flavonoids, were explored for their potential as anti‐TB agents.
Sanderson D. Calixto   +12 more
wiley   +1 more source

Circular RNA as a source of neoantigens for cancer vaccines. [PDF]

open access: yesJ Immunother Cancer
Ren Y   +10 more
europepmc   +1 more source

Millisecond phase transition kinetics of lyotropic liquid crystalline nanoparticles observed by time‐resolved small angle x‐ray solution scattering

open access: yesChemPhysChem, Accepted Article.
This study investigates the dynamic behavior of lyotropic liquid crystal nanoparticles (LCNPs), which are widely recognized for their applications in drug delivery. By employing nanosecond near‐infrared (NIR) laser pulse‐induced temperature jump (T‐jump) and time‐resolved X‐ray solution scattering (TRXSS), the structural dynamics of phase transitions ...
Changmin Lee   +5 more
wiley   +1 more source

Cancer vaccines: from an immunology perspective. [PDF]

open access: yesImmunother Adv
Makker S, Galley C, Bennett CL.
europepmc   +1 more source

Advances in Isotope Labeling for Solution Nucleic Acid Nuclear Magnetic Resonance Spectroscopy

open access: yesChemPlusChem, EarlyView.
Recent advances in the field of nucleic acid nuclear magnetic resonance (NMR) are presented. Stable isotope labeling protocols and new approaches to segmentally label nucleic acid with NMR‐active residues are summarized. The novel methods will have a strong impact on the future of nucleic acid NMR and the characterization of structure and dynamics of ...
Stefan Hilber   +3 more
wiley   +1 more source

Model‐Informed Drug Development Applications and Opportunities in mRNA‐LNP Therapeutics

open access: yesClinical Pharmacology &Therapeutics, EarlyView.
The utilization of lipid nanoparticles (LNP) for encapsulating mRNA has revolutionized the field of therapeutics, enabling the rapid development of COVID‐19 vaccines and cancer vaccines. However, the clinical development of mRNA‐LNP therapeutics faces numerous challenges due to their complex mechanisms of action and limited clinical experience.
Jiawei Zhou   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy